Reuters logo
BRIEF-Cardiome Pharma announces Health Canada approval of AGGRASTAT high dose bolus regimen
July 17, 2017 / 12:25 PM / 5 months ago

BRIEF-Cardiome Pharma announces Health Canada approval of AGGRASTAT high dose bolus regimen

July 17 (Reuters) - Cardiome Pharma Corp

* Cardiome announces Health Canada approval of Aggrastat high dose bolus regimen

* Cardiome Pharma - ‍therapeutic Products Directorate of Health Canada approved aggrastat 25 mcg/kg (high) dose bolus regimen as requested under co SNDS​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below